Back to search

Article

Generation and therapeutic efficacy of the novel Fc-modified cross-neutralizing human monoclonal antibodies against dengue virus

2023-05-26

Abstract excerpt

<h4>Background: </h4> Dengue disease is a mosquito-borne infection caused by four dengue virus serotypes (DENV1–4). Secondary infections can produce flavivirus cross-reactive antibodies at sub-neutralizing levels. This phenomenon can significantly increase the severity of secondary infections via antibody-dependent enhancement (ADE). ADE activity is associated with a high risk of viral infection in immune effector...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9f62b88d-7f0f-5a67-a8cf-95adfece7fe8
DOI
10.1101/2023.05.25.542225
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Generation and therapeutic efficacy of the novel Fc-modified cross-neutralizing human monoclonal antibodies against dengue virusDOI 10.1101/2023.05.25.542225
Select a neighboring publication to make it the new centre.